Leveraging Neoadjuvant and Adjuvant Immunotherapy to Improve Outcomes in Early-Stage Cancers

(1:29:6)

What is Neoadjuvant Therapy? | Dana-Farber Cancer Institute

(3:20)

What is Neoadjuvant Therapy?

(53)

Neoadjuvant vs. Adjuvant vs. None – “Perioperative Therapy”

(22:25)

What are Neoadjuvant and Adjuvant Chemotherapy for Bladder Cancer?

(10:32)

Neoadjuvant Versus Adjuvant Therapy in TNBC

(3:12)

Neoadjuvant and Adjuvant Chemotherapy in Bladder Cancer

(20:29)

What is the difference between adjuvant and neoadjuvant therapy?

(56)

The predictive value of treatment response after neoadjuvant therapy

(1:29)

Exploring Neoadjuvant Therapy for Breast Cancer: What You Need to Know

(10:5)

S1 Episode 4: Managing Lung Cancer With Neoadjuvant and Adjuvant Therapy

(24:30)

What is Neoadjuvant Therapy?

(1:35)

Dr. Kelly on Preliminary Data With Neoadjuvant Immunotherapy in Lung Cancer

(1:24)

Reinventing Clinical Trials with Laura Esserman

(26:51)

Dr. Tereffe on Treatment After Neoadjuvant Chemotherapy in Breast Cancer

(1:10)

Dr. Weksler on Neoadjuvant and Adjuvant Therapy in NSCLC

(59)

ALTERNATE: neoadjuvant chemotherapy in ER+ HER2- breast cancer

(3:1econd)

Expanding Treatment in The Neoadjuvant Setting

(33)

Analyzing Predictors of Response to Neoadjuvant Chemotherapy in Breast Cancer

(1:22)